Imatinib as the first-line treatment of patients with chronic myeloid leukemia diagnosed in the chronic phase: Can we compare real life data to the results from clinical trials?

✍ Scribed by Daniela Zackova; Hana Klamova; Ladislav Dusek; Jan Muzik; Katerina Machova Polakova; Jana Moravcova; Tomas Jurcek; Dana Dvorakova; Zdenek Racil; Zdenek Pospisil; Alexandra Oltova; Kyra Michalova; Jana Brezinova; Filip Razga; Michael Doubek; Petr Cetkovsky; Marek Trneny; Jiri Mayer

• Publisher: John Wiley and Sons
• Year: 2011
• Tongue: English
• Weight: 286 KB
• Volume: 86
• Category: Article
• ISSN: 0361-8609
• DOI: 10.1002/ajh.21942